HHealthcare Read More Medicare spending far less than expected on new Alzheimer’s drugsMay 11, 2026 Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
HHealthcare Read More Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drugMay 9, 2026 Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
HHealthcare Read More Taking too many medications may harm older adults, study warnsMay 9, 2026 Patients with many chronic diseases are prescribed by their personal physician and specialists a large number of pills…
HHealthcare Read More 3 Stocks Poised to Disrupt the Healthcare Market by 2030May 9, 2026 The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
HHealthcare Read More CVS Health (CVS) earnings Q1 2026May 6, 2026 A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
HHealth Read More Weight-Loss Drugs Like Ozempic May Come With an Unexpected CostMay 6, 2026 Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…
HHealthcare Read More Pfizer (PFE) earnings Q1 2026May 6, 2026 Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
BBusiness Read More Origin Materials to shut down; biotech IPOs boomMay 5, 2026 Last May, C&EN launched a new column called Eye on Patents. (The following month we debuted another new…
HHealthcare Read More UnitedHealth, Cigna, Humana earnings show insurers are recoveringMay 5, 2026 Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
HHealthcare Read More 1 Healthcare Stock to Target This Week and 2 Facing HeadwindsMay 2, 2026 From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But…
HHealth Read More Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke RiskMay 2, 2026 GLP-1 receptor agonists are showing evidence of sustained cardiovascular effects beyond their established metabolic benefits. Long-term trial data…
MMedication Read More FDA proposes excluding Novo, Lilly GLP-1s from compounding listApril 30, 2026 The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…